EHC/X
Oct 17, 2025, 08:28
EHC New Tech 2025: Join to Explore Advances in Bleeding Disorders Treatments
The European Haemophilia Consortium (EHC) shared on X:
”Just two weeks to the EHC New Tech 2025!
Join us on Oct 31–Nov 2 in Ljubljana to explore advances in Bleeding Disorders treatments.
Limited to EHC NMOs and HCPs—secure your spot!”
New products for bleeding disorders are expected to enter the European market in the future.
EHC New Tech 2025 will explore the underlying technologies of these innovations and examine strategies to ensure patient access—particularly focusing on their economic sustainability.
Don’t miss it! Register here.
Stay updated with Hemostasis Today.
-
Dec 7, 2025, 17:01Abdul Mannan: How Do You Manage a Major Surgery When Blood Transfusion is Impossible?
-
Dec 7, 2025, 16:51Ahmed Bahi on Lina Merghani’s Critique of Early Withdrawal of Aspirin after PCI
-
Dec 7, 2025, 16:30Eloïse Laouenan Presents the Results of HEMOTHEPP-CHU Brest-GETBO Prospective Study
-
Dec 7, 2025, 16:21Jonathan Douxfils: Can We Estimate the VTE Risk of a Pill Before a Million Women Use It?
-
Dec 7, 2025, 16:06Pablo Corral on Why Early LDL-C Reduction Saves Lives
-
Dec 7, 2025, 15:53Paul Batty Congratulates Giulia Simini on Taking The Joint BSH-ASH Abstract Award
-
Dec 7, 2025, 15:35Federica Fogacci Presents The New ILEP Consensus Paper
-
Dec 7, 2025, 15:20Deep Molecular Modeling for Type 2A VWD from Omid Seidizadeh
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights